Navigation Links
New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace

First comprehensive study of market dynamics offers insights into what will be needed to get new, faster and better TB drugs to patients

NEW YORK, May 14, 2007 /PRNewswire-USNewsire/ -- The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today released results from the first comprehensive study of the dynamics of the global TB drug market that offers a detailed analysis of how today's TB medicines reach patients around the world, and an estimate of the value of the global market for first-line TB treatments.

The study, Pathway to Patients: Charting the Dynamics of the Global TB Drug Market, reveals the variability and complexities faced at all levels of the TB drug supply chain; the highly fragmented nature of the global marketplace in terms of purchase, supply and delivery; the important role of local and national governments in procurement and distribution; and the limited commercial market potential for new TB drugs.

"The absence of a viable commercial market has clearly held back TB drug research for decades," said Maria C. Freire, CEO and President of the TB Alliance. "This groundbreaking study reaffirms the mission of the TB Alliance to develop new, faster and better TB drugs, and the importance of working to ensure these lifesaving new cures reach all those who need them."

Pathway to Patients studied the TB drug market in ten strategically selected countries, including high burden, emerging and high income markets (Brazil, China, France, India, Indonesia, Japan, the Philippines, South Africa, the United Kingdom and the United States) to obtain country specific market data and provide a comprehensive understanding in eight key countries of procurement and distribution systems.

The study projects an estimate of the global market for first-line TB drugs of approxim
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/2/2015)... , July 2, 2015  Before you head outdoors with ... you can stay safe and healthy. Take steps to protect ... http://nyackhospital.org/summersafety Protect Your Skin From the ... sun can increase your risk of skin cancer. To protect ... much as possible, especially during midday hours. Wear a hat ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) ... by Analog, Application, End-User & by Region - Global Trends ... This market is projected to reach about $2.5 Million ... applications and rising opportunities in countries such as ... Italy , and Brazil . In ...
(Date:7/2/2015)... 2, 2015 Numotion,s Board of Directors and ... Tamas Feitel has joined the Company as ... a highly successful 18 year career at GE serving ... profitability, and productivity to result in significant industry leading ... Chief Financial Officer for GE Healthcare Global Services, a ...
Breaking Medicine Technology:First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2
... TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - Accentia,Biopharmaceuticals, Inc. ... of the American Academy of Allergy, Asthma, and,Immunology ... Diego, CA. The,posters discussed findings from a survey ... U.K., France, and Germany on the,burden of chronic ...
... trial data underlines M6G's,benefit compared to morphine ... England, 7th March 2007 - CeNeS Pharmaceuticals ... today,announces additional data from the pivotal Phase ... 500 patients with,post-operative pain. The preliminary data ...
Cached Medicine Technology:Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7
(Date:7/3/2015)... Greenville, SC (PRWEB) , ... ... ... Society has announced the sessions and speaker lineup for its 2015 ... nursing, taking place August 6-8, 2015 at the Renaissance Orlando at SeaWorld ...
(Date:7/3/2015)... ... 03, 2015 , ... The Erie County Bar Association Institute ... The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... investigating these types of cases. , Each year, New York State residents are ...
(Date:7/3/2015)... ... , ... " Selfie on a Stick ” was featured on NewsWatch as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... memories. , Almost every smartphone has an incredibly powerful camera built into it. And ...
(Date:7/2/2015)... Richmond, VA (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... the 18th sweetFrog store located in the Lone Star State. The premium frozen yogurt chain ... , The store, which opened June 19 in the Village at Bachman Lake, is located ...
(Date:7/2/2015)... RI (PRWEB) , ... July 02, 2015 , ... Many ... safety in mind. That’s why Amica Insurance is sharing some tips to ... Commission (CPSC), approximately 230 people go to the emergency room daily with fireworks-related injuries ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2
... you taking or did you take hormones? If yes, which ... taking hormone replacement medication? 3,464 breast cancer patients and 6,657 ... participated in a large survey and elicited detailed information about ... for relief of menopausal symptoms. The survey was prompted by ...
... German . , A measuring procedure developed ... in some detail the behaviour of magnetic nanoparticles which ... a size of some few to several hundred nanometres) ... particles serve as a carrier for drugs: "loaded" with ...
... food that boosts the uptake of iron and offers a ... of a doctoral dissertation by Charlotte Eklund-Jonsson at the Department ... The food, called tempe, is moreover a whole-grain product with ... that whole-grains reduce the risk of cardiovascular diseases, and it ...
... Will Rise by Nearly 19 Percent as a Result of ... ... Resources, WALTHAM, ... and advisory firms for pharmaceutical and,healthcare issues, finds that the launches ...
... 28 CYNACON / OCuSOFT(R),(OCuSOFT(R), Inc.), a ... to ophthalmologists and optometrists, is pleased to,announce ... OCuSOFT(R) Lid Scrub(TM),Plus is now available in ... *(Photo Caption: OCuSOFT(R) Lid Scrub(TM) PLUS), ...
... to be hospitalized, study finds , , WEDNESDAY, May 28 ... smoke around kids: , In addition to developing asthma ... are more likely to catch a whole range of ... be hospitalized, a new study found. , Being around ...
Cached Medicine News:Health News:Long-term hormone replacement therapy increases breast cancer risk 2Health News:Magnetic nanoparticles: Suitable for cancer therapy? 2Health News:Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017 2Health News:CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies 2Health News:Secondhand Smoke Leaves Kids Prone to Severe Infections 2Health News:Secondhand Smoke Leaves Kids Prone to Severe Infections 3
Rhoton Curettes, titanium, length 191 mm, straight....
Temporary...
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: